What we do
Based at the UCL School of Pharmacy in the heart of London, the Basit Research Group is a large multi-disciplinary team that brings our individual expertise together to translate drug delivery into improved patient outcomes. We have developed a number of advanced drug delivery technologies that have entered the pharmaceutical market and more importantly, to the clinic as an approved drug. To date, over a million patients worldwide have benefited from the inventions created and developed in our group. Together, and with collaboration efforts, we will continue to deliver better medicines so that patients receive a better quality of life.
With over two decades of research, our group has developed a strong understanding of the gastrointestinal system evaluating sex differences, food effects and disease states to personalise oral drug delivery.
Standing at the fore of developing modern pharmaceutical manufacturing techniques, our world-leading 3D printing research spans the fabrication of personalised medicines, drug delivery devices and process analytical technologies.
Artificial intelligence and machine learning has the potential to transform drug development. Our group aims to incorporate 3D printing, point-of-care theranostics and digital transformation into the emerging field of digital health in pharmaceutics.
Meet the Team
Papers & Patents00000
Over 250 published papers and granted patents
Garnered over 18,000 citations and awarded as a 'Highly Cited Research' team in 2021
Over 50 successful alumni working in academia, industry and biotech companies
Products & Technologies00000
Over 6 advanced drug delivery systems brought to market
January 25, 2023
Advancing oral delivery of biologics: Machine learning predicts peptide stability in the gastrointestinal tract
January 23, 2023
Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats
January 20, 2023